DPP4 and type 2 diabetes mellitus: Two international collaborations—between Tufts Medical Center/Tufts University/University of Toronto and between the Hans-Knoell-Institute/University of British Columbia—discovered the use of dipeptidyl peptidase-IV inhibitors to treat type 2 diabetes.